Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrizio Conti

Showing results (301-310 of 347) with videos related to

Pageof 35
Sort By:
BMC Health Services Research|December 16, 2022
A real-world economic analysis of biologic therapies for psoriatic arthritis in Italy: results of the CHRONOS observational longitudinal studyEmanuela Zagni, Micol Frassi, Giuseppa Pagano Mariano, et al.
Rheumatology (Oxford, England)|February 25, 2024
Therapeutic strategies and outcomes in neuropsychiatric systemic lupus erythematosus: an international multicentre retrospective studyAlessandra Bortoluzzi, Antonis Fanouriakis, Ettore Silvagni, et al.
Frontiers in Immunology|October 4, 2018
Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsALoredana Frasca, Raffaella Palazzo, Maria S Chimenti, et al.
Clinical and Experimental Rheumatology|May 4, 2023
Determining the PASS cut-off points for the FIQR, FASmod and PSD in patients with fibromyalgia: a registry-based studyFausto Salaffi, Marco Di Carlo, Manuela Di Franco, et al.
Journal of Autoimmunity|September 23, 2017
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide studyLuca Iaccarino, Laura Andreoli, Elena Bartoloni Bocci, et al.
Therapeutic Advances in Musculoskeletal Disease|February 3, 2025
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA RegistryGiuseppe Lopalco, Maria Morrone, Fabiola Atzeni, et al.
Rheumatology (Oxford, England)|August 4, 2025
Targeting axial and peripheral psoriatic arthritis: a retrospective observational study on the clinical relevance of upadacitinibGiuseppe Lopalco, Eleonora Celletti, Maria Morrone, et al.
Lupus|April 22, 2021
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for RheumatologyGian Domenico Sebastiani, Francesca Romana Spinelli, Elena Bartoloni, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 6, 2025
ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in patients with rheumatological diseasesMaria Giulia Caponcello, Paula Olivares Navarro, Cecilia Bonazzetti, et al.
Clinical and Experimental Rheumatology|August 31, 2023
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDsLaura Scagnellato, Antonio Collesei, Andrea Doria, et al.
Pageof 35

Showing results (301-310 of 347) with videos related to

Sort By:
Pageof 35
BMC Health Services Research|December 16, 2022
A real-world economic analysis of biologic therapies for psoriatic arthritis in Italy: results of the CHRONOS observational longitudinal studyEmanuela Zagni, Micol Frassi, Giuseppa Pagano Mariano, et al.
Rheumatology (Oxford, England)|February 25, 2024
Therapeutic strategies and outcomes in neuropsychiatric systemic lupus erythematosus: an international multicentre retrospective studyAlessandra Bortoluzzi, Antonis Fanouriakis, Ettore Silvagni, et al.
Frontiers in Immunology|October 4, 2018
Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsALoredana Frasca, Raffaella Palazzo, Maria S Chimenti, et al.
Clinical and Experimental Rheumatology|May 4, 2023
Determining the PASS cut-off points for the FIQR, FASmod and PSD in patients with fibromyalgia: a registry-based studyFausto Salaffi, Marco Di Carlo, Manuela Di Franco, et al.
Journal of Autoimmunity|September 23, 2017
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide studyLuca Iaccarino, Laura Andreoli, Elena Bartoloni Bocci, et al.
Therapeutic Advances in Musculoskeletal Disease|February 3, 2025
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA RegistryGiuseppe Lopalco, Maria Morrone, Fabiola Atzeni, et al.
Rheumatology (Oxford, England)|August 4, 2025
Targeting axial and peripheral psoriatic arthritis: a retrospective observational study on the clinical relevance of upadacitinibGiuseppe Lopalco, Eleonora Celletti, Maria Morrone, et al.
Lupus|April 22, 2021
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for RheumatologyGian Domenico Sebastiani, Francesca Romana Spinelli, Elena Bartoloni, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 6, 2025
ORCHESTRA Delphi consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in patients with rheumatological diseasesMaria Giulia Caponcello, Paula Olivares Navarro, Cecilia Bonazzetti, et al.
Clinical and Experimental Rheumatology|August 31, 2023
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDsLaura Scagnellato, Antonio Collesei, Andrea Doria, et al.
Pageof 35